Free Trial

Genus (LON:GNS) Reaches New 52-Week Low - Here's Why

Genus logo with Medical background

Genus plc (LON:GNS - Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 1,448 ($17.68) and last traded at GBX 1,448 ($17.68), with a volume of 100926 shares traded. The stock had previously closed at GBX 1,480 ($18.07).

Wall Street Analysts Forecast Growth

Separately, Shore Capital reissued a "buy" rating on shares of Genus in a research note on Wednesday, December 11th.

Check Out Our Latest Stock Report on Genus

Genus Stock Performance

The stock has a market capitalization of £933.72 million, a price-to-earnings ratio of 11,866.67, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.54. The company has a 50 day simple moving average of GBX 1,664.98 and a 200-day simple moving average of GBX 1,783.39.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Stories

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines